BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Crospon Receives FDA Clearance for Barostat Option for EndoFLIP System


8/29/2012 7:05:56 AM

29th August 2012 – – Crospon, a medical device developer based in Galway, Ireland has today announced that it has received FDA clearance for the first use of its EndoFLIP system in gastroenterology applications.

The newly cleared Barostat software option extends the FDA cleared uses for the EndoFLIP system beyond measurements taken during gastric band and sleeve gastrectomy bariatric surgery procedures, to now include pressure and dimension measurements taken in the esophagus and as an adjunct to other methods in the comprehensive evaluation of patients with symptoms consistent with esophageal sensory hypersensitivity. All new EndoFLIP systems will include the Barostat software option.

Commenting on the FDA clearance, John O’Dea, CEO, Crospon said, “This clearance is important for Crospon as it, for the first time, allows us to market the EndoFLIP system in the USA for gastroenterology applications. Not only is this the Company’s first cleared application for gastroenterology, but it also represents the first reimbursed application for the product”.

The Company was recently awarded the 2012 European Enabling Technology Award for Surgical Imaging Technology by Frost & Sullivan.

For Further Information please contact

John McGuinness

Murray Consultants

jmcguinness@murrayconsult.ie

00353 1 498 0361

00353 87 6417451

www.endoflip.com



Read at BioSpace.com
Read at News Release
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES